Evidence map›Paper›PMID 33478594›Full record

ArticleEuropean journal of medical research2021

LncRNA NEAT1 promotes nucleus pulposus cell matrix degradation through regulating Nrf2/ARE axis.

Cheng Li, Xinjian Ma, Chenfei Ni, Jingyan Xu, Yinfei Xie, Junwei Kan, Xiaoli Wei

Open access · goldAbstract read
In one paragraph

Article in European journal of medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Cheng LiDepartment of Rehabilitation Medicine, Affiliated Hospital of Jiangnan University, Wuxi, 214041, Jiangsu, China.
Xinjian MaDepartment of Traditional Chinese Medicine, Wuxi Guangrui and Tongjiang Community Health Service Center, Wuxi, 214000, Jiangsu, China.
Chenfei NiDepartment of Rehabilitation Medicine, Affiliated Hospital of Jiangnan University, Wuxi, 214041, Jiangsu, China.
Jingyan XuDepartment of Acupuncture, Affiliated Hospital of Jiangnan University (Formerly the Third People's Hospital), No.585 Xingyuan North Road, Liangxi District, Wuxi, 214041, Jiangsu, China.
Yinfei XieDepartment of Acupuncture, Affiliated Hospital of Jiangnan University (Formerly the Third People's Hospital), No.585 Xingyuan North Road, Liangxi District, Wuxi, 214041, Jiangsu, China.
Junwei KanDepartment of Rehabilitation Medicine, Affiliated Hospital of Jiangnan University, Wuxi, 214041, Jiangsu, China.
Xiaoli WeiDepartment of Acupuncture, Affiliated Hospital of Jiangnan University (Formerly the Third People's Hospital), No.585 Xingyuan North Road, Liangxi District, Wuxi, 214041, Jiangsu, China. xi36267@163.com.
Wuxi Fourth People's Hospital · CNJiangnan University · CNWuxi Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to assess the role and mechanism of lncRNA NEAT1 in intervertebral disc degeneration (IVD).

methodsLncRNA profile (GSE56081) between IVD and healthy control was downloaded from the Gene Expression Omnibus (GEO) database and analyzes differential lncRNA expression. Expression of lncRNA NEAT1 in IVD tissue and TNF-α/IL-1β-stimulated nucleus pulposus cells were further measured by RT-PCR. The lncRNA NEAT1 overexpression plasmids (pcDNA-NEAT1) were constructed and transfected into nucleus pulposus cells. Catabolic biomarkers (MMP-3 and MMP-13), anabolic biomarkers (Col II and Aggrecan) and Nrf2 expression were further measured. To further investigate the function of Nrf2, nucleus pulposus cells were pretreated with or without 25 μM tert-Butylhydroquinone (TBHQ), a Nrf2 activator, for 18 h and subsequently cotreated with pcDNA-NEAT1.

resultsA total of 1432 lncRNAs were differentially expressed in GSE56081. Bioinformatic analysis found that these lncRNAs mainly enriched in Nrf2/ARE signaling pathway. LncRNA NEAT1 was highly expressed in IVD tissues than that of healthy control. Moreover, TNF-α/IL-1β induced a time- and dose-dependent increase in the mRNA expression of lncRNA NEAT1 in the nucleus pulposus cells. Overexpression of lncRNA NEAT1 abates promotes nucleus pulposus cells proliferation but induces matrix degradation. Meanwhile, nucleus and cytoplasm Nrf2 expression was significantly down-regulated by lncRNA NEAT1 upregulation. Nrf2 activator (TBHQ) could partially reverse the inhibitory effects of overexpression of lncRNA NEAT1 on matrix degradation.

conclusionCollectively, our data unveiled the lncRNA NEAT1 promotes matrix degradation by regulating Nrf2/ARE signaling pathway, suggesting a potential therapeutic for IVD in the future.

Indexed as

Cell-Matrix JunctionsHumansHydroquinonesInterleukin-1betaIntervertebral Disc DegenerationMatrix Metalloproteinase 13Matrix Metalloproteinase 3MetabolismNF-E2-Related Factor 2Nucleus PulposusRNA, Long NoncodingRNA, MessengerSignal TransductionTumor Necrosis Factor-alpha2-tert-butylhydroquinoneHydroquinonesIL1B protein, humanInterleukin-1betaMatrix Metalloproteinase 13Matrix Metalloproteinase 3NEAT1 long non-coding RNA, humanNFE2L2 protein, humanNF-E2-Related Factor 2RNA, Long NoncodingRNA, MessengerTumor Necrosis Factor-alphaIntervertebral disc degenerationLncRNA NEAT1Nrf2/ARE signaling pathway

Identifiers

PMID33478594
PMCPMC7818737
OpenAlexW3123917129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.